CORCEPT THERAPEUTICS INC (1CORT.MI) Stock Price, Forecast & Analysis
Europe - Euronext Milan - BIT:1CORT - US2183521028 - Common Stock
1CORT.MI Key Statistics, Chart & Performance
The current stock price of 1CORT.MI is 62.7 EUR.
1CORT.MI Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| SNW.DE | SANOFI | 10.84 | 200.10B | ||
| 1SAN.MI | SANOFI | 10.75 | 198.47B | ||
| SAN.PA | SANOFI | 10.74 | 198.23B | ||
| MRK.DE | MERCK KGAA | 14.13 | 52.41B | ||
| 1MRK.MI | MERCK KGAA | 13.94 | 51.72B | ||
| UNC.DE | UCB SA | 37.51 | 46.84B | ||
| UCB.BR | UCB SA | 36.68 | 45.81B | ||
| BAYN.DE | BAYER AG-REG | 6.73 | 35.31B | ||
| 1BAYN.MI | BAYER AG-REG | 6.65 | 34.87B | ||
| REC.MI | RECORDATI INDUSTRIA CHIMICA | 24.71 | 10.18B | ||
| IPN.PA | IPSEN | 11.68 | 10.06B | ||
| TUB.BR | FINANCIERE DE TUBIZE | 100.48 | 9.30B |
Related stock screener links
About 1CORT.MI
Company Profile
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. The company is headquartered in Redwood City, California and currently employs 500 full-time employees. The company went IPO on 2004-04-15. The firm is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The firm operates through the discovery, development and commercialization of the pharmaceutical products segment. The firm has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.
Company Info
CORCEPT THERAPEUTICS INC
101 Redwood Shores Parkway
Redwood City CALIFORNIA US
Employees: 500
Phone: 16506888803
CORCEPT THERAPEUTICS INC / 1CORT.MI FAQ
What does 1CORT do?
Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. The company is headquartered in Redwood City, California and currently employs 500 full-time employees. The company went IPO on 2004-04-15. The firm is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The firm operates through the discovery, development and commercialization of the pharmaceutical products segment. The firm has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.
What is the current price of 1CORT stock?
The current stock price of 1CORT.MI is 62.7 EUR.
Does 1CORT stock pay dividends?
1CORT.MI does not pay a dividend.
What is the ChartMill rating of CORCEPT THERAPEUTICS INC stock?
1CORT.MI has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
Can you provide the sector and industry classification for CORCEPT THERAPEUTICS INC?
CORCEPT THERAPEUTICS INC (1CORT.MI) operates in the Health Care sector and the Pharmaceuticals industry.
Should I buy 1CORT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on 1CORT.MI.
Who owns CORCEPT THERAPEUTICS INC?
You can find the ownership structure of CORCEPT THERAPEUTICS INC (1CORT.MI) on the Ownership tab.
1CORT.MI Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to 1CORT.MI.
1CORT.MI Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to 1CORT.MI. 1CORT.MI gets an excellent profitability rating and is at the same time showing great financial health properties.
1CORT.MI Financial Highlights
Over the last trailing twelve months 1CORT.MI reported a non-GAAP Earnings per Share(EPS) of 0.99. The EPS increased by 9.43% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 19.55% | ||
| ROA | 15.83% | ||
| ROE | 19.61% | ||
| Debt/Equity | 0 |
1CORT.MI Forecast & Estimates
For the next year, analysts expect an EPS growth of 13.31% and a revenue growth 29.78% for 1CORT.MI